Results 151 to 160 of about 19,807 (208)

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma. [PDF]

Medicina (Kaunas)
Brenner R, Edri HTF, Rouvinov K, Shani Shrem N, Meirovitz A, El-Saied S, Berezhnov I, Ievko A, Turaieva S, Fenig S, Abu Yasin N, Fenig E, Hussany S, Yakobson A, Shalata W.   +14 more
europepmc   +1 more source

A 30-Year Single-Centre Series of Unknown Primary Merkel Cell Carcinoma: Management and Prognosis. [PDF]

Cancers (Basel)
Bini A, Totorean R, Kumar H, Grecu T, Shenjere P, Oudit D.   +5 more
europepmc   +1 more source

Primary Merkel cell carcinoma of the submandibular region without cutaneous lesion: a case report. [PDF]

Arch Craniofac Surg
Lee HM, Lee RW, Lee HH, Na YC.
europepmc   +1 more source

Outcomes and comorbidities of Merkel cell carcinoma: A retrospective cohort study utilizing the Mayo Clinic platform. [PDF]

JAAD Int
Amjad SA, Koblinski JE, Starghill M, Shao S, Breinholt J, Jakub JW, Arpey CJ, Baum CL, Pirgousis P, Dronca RS, Mangold AR, Costello CM.   +11 more
europepmc   +1 more source

Immunosuppression Outweighs Clinical AEIOU Heuristics in Predicting Disease Progression of Merkel Cell Carcinoma: A Retrospective Cohort Study. [PDF]

Acta Derm Venereol
Chiarella LS, Kupina E, Kückelhaus M, Hirsch T, Schulze HJ, Raguse JD, Wellenbrock S.   +6 more
europepmc   +1 more source

Checkpoint Inhibitor-Treated Merkel Cell Carcinoma With Cytokeratin 20 (CK20)-Negative Metastatic Immunophenotypic Divergence: Diagnostic and Therapeutic Implications. [PDF]

Cureus
Berlingeri Collazo D, Cintron Perez L, Torres Troche E, Vora S.   +3 more
europepmc   +1 more source